Search

everythinglearnresearchcommunity

for

Search:↓

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Alternative treatments show promise for hair growth beyond traditional methods.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgens can both increase body hair and cause scalp hair loss.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

MorrF improves hair growth better than minoxidil alone.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Treating melasma in men is difficult, especially for the deeper skin layers, and may need more than just topical treatments.

Treat hair loss with medicine, continue indefinitely.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Gender identity can be more diverse than just male or female.